The drugmaker shed billions of dollars in value after it told investors that widening Journavx’s approval to chronic pain ...

Challenges persist despite promising advance In January 2025, the National Institute for Health and Care Excellence (NICE) approved the use of the gene editing therapy exagamglogene autotemcel ...

Google DeepMind CEO Demis Hassabis heads Gemini and the company's AI push while gaining more power. Here's how he became ...

Businesses have always relied on data, but they never were able to get full value out of them when they were siloed by structure, system, or storage.

CASGEVY® momentum building; >75 authorized treatment centers (ATCs) activated globally, achieving the target goal and ~115 ...